Market Cap ₹103 Cr.
Stock P/E 21.8
P/B 0.9
Current Price ₹51.1
Book Value ₹ 54.5
Face Value 10
52W High ₹59.3
Dividend Yield 0%
52W Low ₹ 19.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 23 | 53 | 36 | 45 | 24 | 18 | 12 | 31 | 17 | 22 |
Other Income | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 2 |
Total Income | 24 | 53 | 36 | 47 | 25 | 18 | 12 | 31 | 18 | 24 |
Total Expenditure | 20 | 48 | 32 | 40 | 20 | 15 | 8 | 20 | 14 | 22 |
Operating Profit | 4 | 6 | 5 | 7 | 5 | 4 | 4 | 11 | 3 | 2 |
Interest | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 2 | -0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 2 | 1 | 3 | 1 | 1 | 1 | 5 | -0 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Profit After Tax | 1 | 2 | 1 | 3 | 1 | 1 | 1 | 4 | -0 | 0 |
Adjustments | -0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 |
Profit After Adjustments | 1 | 2 | 1 | 3 | 1 | 1 | 1 | 4 | -0 | 0 |
Adjusted Earnings Per Share | 0.3 | 0.8 | 0.5 | 1.6 | 0.7 | 0.4 | 0.3 | 2 | -0.1 | 0.2 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 103 | 116 | 122 | 92 | 161 | 86 | 82 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Total Income | 103 | 117 | 123 | 92 | 161 | 87 | 85 |
Total Expenditure | 86 | 97 | 103 | 73 | 139 | 62 | 64 |
Operating Profit | 17 | 20 | 19 | 19 | 22 | 25 | 20 |
Interest | 9 | 11 | 9 | 9 | 10 | 10 | 9 |
Depreciation | 7 | 7 | 6 | 6 | 5 | 7 | 7 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 2 | 4 | 4 | 7 | 7 | 6 |
Provision for Tax | -0 | -0 | -0 | 0 | 0 | 1 | 1 |
Profit After Tax | 1 | 2 | 4 | 4 | 7 | 7 | 5 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 2 | 4 | 4 | 7 | 7 | 5 |
Adjusted Earnings Per Share | 0.7 | 1.1 | 2.1 | 1.8 | 3.3 | 3.3 | 2.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -47% | -11% | -4% | 0% |
Operating Profit CAGR | 14% | 10% | 8% | 0% |
PAT CAGR | 0% | 21% | 48% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 143% | 55% | 34% | 12% |
ROE Average | 6% | 6% | 5% | 4% |
ROCE Average | 8% | 8% | 8% | 7% |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Shareholder's Funds | 87 | 89 | 92 | 94 | 104 | 109 |
Minority's Interest | 0 | 0 | 3 | 5 | 6 | 8 |
Borrowings | 52 | 53 | 67 | 69 | 61 | 70 |
Other Non-Current Liabilities | 3 | 2 | 2 | 3 | 2 | 3 |
Total Current Liabilities | 37 | 35 | 37 | 37 | 42 | 45 |
Total Liabilities | 179 | 179 | 201 | 207 | 216 | 235 |
Fixed Assets | 76 | 71 | 72 | 67 | 64 | 80 |
Other Non-Current Assets | 1 | 6 | 4 | 1 | 1 | 5 |
Total Current Assets | 102 | 103 | 125 | 139 | 152 | 150 |
Total Assets | 179 | 179 | 201 | 207 | 216 | 235 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 2 | 1 | 8 | 2 | -20 |
Cash Flow from Operating Activities | 12 | 22 | 7 | 4 | 6 | 33 |
Cash Flow from Investing Activities | -4 | -6 | -5 | -1 | -27 | -24 |
Cash Flow from Financing Activities | -7 | -16 | 5 | -9 | -1 | 1 |
Net Cash Inflow / Outflow | 0 | -1 | 7 | -6 | -22 | 10 |
Closing Cash & Cash Equivalent | 2 | 1 | 8 | 2 | -20 | -11 |
# | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.68 | 1.06 | 2.12 | 1.77 | 3.32 | 3.33 |
CEPS(Rs) | 4.26 | 4.68 | 5.11 | 4.52 | 5.85 | 7.01 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 43.13 | 44.19 | 45.65 | 46.8 | 51.95 | 54.38 |
Core EBITDA Margin(%) | 16.81 | 16.98 | 15.47 | 20.08 | 13.24 | 28.31 |
EBIT Margin(%) | 9.9 | 10.83 | 10.65 | 14.15 | 10.23 | 20.14 |
Pre Tax Margin(%) | 1.13 | 1.73 | 3.45 | 4.06 | 4.3 | 8.44 |
PAT Margin (%) | 1.33 | 1.83 | 3.48 | 3.87 | 4.16 | 7.74 |
Cash Profit Margin (%) | 8.29 | 8.07 | 8.39 | 9.9 | 7.33 | 16.3 |
ROA(%) | 0.67 | 1.19 | 2.24 | 1.74 | 3.15 | 2.96 |
ROE(%) | 1.93 | 2.43 | 4.72 | 3.82 | 6.72 | 6.26 |
ROCE(%) | 5.6 | 7.38 | 7.26 | 6.84 | 8.43 | 8.46 |
Receivable days | 132.74 | 131.27 | 141.47 | 220.04 | 131.6 | 198.93 |
Inventory Days | 122.03 | 127.31 | 120.44 | 187.09 | 137.14 | 306.2 |
Payable days | 71.98 | 18.18 | 25.01 | 47.31 | 24.55 | 79.77 |
PER(x) | 25.31 | 10.99 | 0 | 9.57 | 6.6 | 5.3 |
Price/Book(x) | 0.4 | 0.26 | 0 | 0.36 | 0.42 | 0.32 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.14 | 0.9 | 0.89 | 1.42 | 0.85 | 1.54 |
EV/Core EBITDA(x) | 6.73 | 5.27 | 5.7 | 7.01 | 6.31 | 5.36 |
Net Sales Growth(%) | -44.65 | 12.89 | 5.07 | -25.02 | 74.95 | -46.14 |
EBIT Growth(%) | -35.17 | 23.39 | 3.41 | -0.4 | 26.52 | 5.99 |
PAT Growth(%) | -59.48 | 55.4 | 100.4 | -16.82 | 88.08 | 0.27 |
EPS Growth(%) | -59.48 | 55.4 | 100.4 | -16.82 | 88.08 | 0.27 |
Debt/Equity(x) | 0.97 | 0.93 | 1.05 | 1.04 | 0.9 | 0.96 |
Current Ratio(x) | 2.75 | 2.97 | 3.36 | 3.78 | 3.6 | 3.32 |
Quick Ratio(x) | 1.64 | 1.81 | 2.27 | 2.33 | 2 | 1.6 |
Interest Cover(x) | 1.13 | 1.19 | 1.48 | 1.4 | 1.73 | 1.72 |
Total Debt/Mcap(x) | 2.43 | 3.52 | 0 | 2.88 | 2.13 | 2.95 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 68.82 | 68.82 | 68.82 | 68.82 | 68.82 | 68.82 | 68.82 | 68.82 | 68.82 | 68.82 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 | 31.18 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About